Anlon Healthcare subscribed 1.7 times at end of Day 1

The initial public offering of Anlon Healthcare Ltd, a chemical manufacturing company engaged in producing high purity advanced pharmaceutical intermediates, enters Day 2 with retail investors showing keen interest. The IPO that will close on Friday, is priced in a band of ₹86-₹91 The total issue size is ₹121.03 crore, entirely a fresh issue of 1.33 crore shares. The issue has so far been subscribed 1.69 times. The market lot is 164 shares. While it has reserved 75 per cent of the offer to Qualified Institutional Buyers, non-institutional investors can bid up to 15 per cent and the retail up to 10 per cent. The quota reserved for retail investors was subscribed 8.99 times, followed by NIIs (0.71 time) and QIBs (0.91 time). The net proceeds from the IPO will be utilised for funding capital expenditure requirements for the company’s manufacturing facility, full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the company, for working capital requirements, and general corporate purposes. The Book Running Lead Manager to the issue is Interactive Financial Services Ltd, and the Registrar is KFinTechnologies Ltd. Published on August 28, 2025